Sowing the seeds of cancer: telomeres and age-associated tumorigenesis

Purpose of review Advances in the health system and medical sciences are continuously pushing the barrier of life-expectancy. As a consequence, humans are being increasingly afflicted by age-associated diseases, such as cancer. The challenge now lies in understanding the mechanisms underlying ageing in order to reduce the lifetime risk for cancer. Recent findings In long-lived mammals, telomere length and restriction of telomerase activity are important barriers preventing the uncontrolled cell division. Absence of telomerase dictates the continuous telomere erosion with each cell division, thus restraining the proliferation of incipient tumour cells. However, recent findings have revealed the unintended consequences of telomere control of cell division. Cells with short telomeres accumulate in older individuals increasing the risk of telomere depletion. Loss of telomere protection results in tetraploidization and genomic instability characteristic of epithelial cancers. Additionally, telomere shortening blocks cell proliferation and induces cell senescence. Senescent cells secrete proinflammatory factors and reactive oxygen species that increase the likelihood of cellular transformation and create the perfect soil for cancer development. Summary Telomere shortening thus provides an example of antagonist pleiotropy, in which a beneficial characteristic that acts during the reproductive years of an organism may, later in life, contain the seed to its demise.

[1]  J. Ferlay,et al.  Global estimates of cancer prevalence for 27 sites in the adult population in 2008 , 2013, International journal of cancer.

[2]  T. Davoli,et al.  Telomere-driven tetraploidization occurs in human cells undergoing crisis and promotes transformation of mouse cells. , 2012, Cancer cell.

[3]  Kerstin Schneeberger,et al.  Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer , 2012, EMBO molecular medicine.

[4]  M. Hande,et al.  Oncogene-induced telomere dysfunction enforces cellular senescence in human cancer precursor lesions , 2012, The EMBO journal.

[5]  F. D. D. Fagagna,et al.  Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation , 2012, Nature Cell Biology.

[6]  Gerald C. Chu,et al.  Telomerase Reactivation following Telomere Dysfunction Yields Murine Prostate Tumors with Bone Metastases , 2012, Cell.

[7]  M. Blagosklonny Cell cycle arrest is not yet senescence, which is not just cell cycle arrest: terminology for TOR-driven aging , 2012, Aging.

[8]  Colin S. Gillespie,et al.  A Stochastic Step Model of Replicative Senescence Explains ROS Production Rate in Ageing Cell Populations , 2012, PloS one.

[9]  J. Shay,et al.  Is telomerase a viable target in cancer? , 2012, Mutation research.

[10]  J. Murnane,et al.  Telomere dysfunction and chromosome instability. , 2012, Mutation research.

[11]  Clara Correia-Melo,et al.  Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence , 2012, Nature Communications.

[12]  N. LeBrasseur,et al.  Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders , 2011, Nature.

[13]  M. Pagel,et al.  Comparative biology of mammalian telomeres: hypotheses on ancestral states and the roles of telomeres in longevity determination , 2011, Aging cell.

[14]  C. Harley,et al.  The telomerase activator TA‐65 elongates short telomeres and increases health span of adult/old mice without increasing cancer incidence , 2011, Aging cell.

[15]  F. D. D. Fagagna,et al.  Never-ageing cellular senescence , 2011, European journal of cancer.

[16]  J. DeGregori Evolved tumor suppression: why are we so good at not getting cancer? , 2011, Cancer research.

[17]  C. Maley,et al.  Peto's Paradox: evolution's prescription for cancer prevention. , 2011, Trends in ecology & evolution.

[18]  M. Bronner,et al.  Ulcerative colitis-associated colorectal cancer arises in a field of short telomeres, senescence, and inflammation. , 2011, Cancer research.

[19]  J. Campisi,et al.  Four faces of cellular senescence , 2011, The Journal of cell biology.

[20]  L. Chin,et al.  Telomere dysfunction induces metabolic and mitochondrial compromise , 2011, Nature.

[21]  J. Campisi,et al.  DNA-SCARS: distinct nuclear structures that sustain damage-induced senescence growth arrest and inflammatory cytokine secretion , 2011, Journal of Cell Science.

[22]  Toru M. Nakamura,et al.  Telomeres avoid end detection by severing the checkpoint signal transduction pathway , 2010, Nature.

[23]  M. Lynch Evolution of the mutation rate. , 2010, Trends in genetics : TIG.

[24]  L. Lau,et al.  The Matricellular Protein CCN1/CYR61 Induces Fibroblast Senescence and Restricts Fibrosis in Cutaneous Wound Healing , 2010, Nature Cell Biology.

[25]  T. Lange,et al.  Persistent Telomere Damage Induces Bypass of Mitosis and Tetraploidy , 2010, Cell.

[26]  P. Edwards Fusion genes and chromosome translocations in the common epithelial cancers , 2009, The Journal of pathology.

[27]  R. DePinho,et al.  Telomeres and telomerase in cancer. , 2010, Carcinogenesis.

[28]  T. de Lange How Telomeres Solve the End-Protection Problem , 2009, Science.

[29]  Alberto Mantovani,et al.  Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. , 2009, Carcinogenesis.

[30]  Judith Campisi,et al.  Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor , 2008, PLoS biology.

[31]  Jonathan Melamed,et al.  Chemokine Signaling via the CXCR2 Receptor Reinforces Senescence , 2008, Cell.

[32]  P. Hornsby,et al.  Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion. , 2007, Cancer research.

[33]  Jessie C. Jeyapalan,et al.  Accumulation of senescent cells in mitotic tissue of aging primates , 2007, Mechanisms of Ageing and Development.

[34]  J. Campisi,et al.  Secretion of Vascular Endothelial Growth Factor by Primary Human Fibroblasts at Senescence* , 2006, Journal of Biological Chemistry.

[35]  J. Campisi,et al.  Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation , 2004, Journal of Cell Science.

[36]  M. A. Goldman The role of telomeres and telomerase in cancer. , 2003, Drug discovery today.

[37]  R. DePinho,et al.  Constitutive telomerase expression promotes mammary carcinomas in aging mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Shay,et al.  Telomerase and differentiation in multicellular organisms: turn it off, turn it on, and turn it off again. , 2002, Differentiation; research in biological diversity.

[39]  J. Campisi,et al.  Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[40]  M. Blasco,et al.  Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes , 2001, The EMBO journal.

[41]  Lynda Chin,et al.  Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice , 2000, Nature.

[42]  C. Harley,et al.  Extension of life-span by introduction of telomerase into normal human cells. , 1998, Science.

[43]  J. Shay,et al.  A survey of telomerase activity in human cancer. , 1997, European journal of cancer.

[44]  C. Harley,et al.  Telomeres shorten during ageing of human fibroblasts , 1990, Nature.

[45]  P. N. Lee,et al.  Cancer and ageing in mice and men. , 1975, British Journal of Cancer.

[46]  L. Hayflick,et al.  The serial cultivation of human diploid cell strains. , 1961, Experimental cell research.

[47]  P. Medawar UNSOLVED problem of biology. , 1953, The Medical journal of Australia.